ArticleLiver international : official journal of the International Association for the Study of the Liver2025
Update on Hepatitis E Virus Infection 2025: Insights From an International Symposium.
Article in Liver international : official journal of the International Association for the Study of the Liver, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Why does the world continue to struggle with effectively addressing hepatitis E?EXCLI journal · 2026Article
- Risk factors analysis for progression to severe hepatitis in acute hepatitis E: a retrospective study of 146 hospitalized cases.BMC infectious diseases · 2025Article
- Update on Hepatitis E Virus Infection 2025: Insights From an International Symposium.Liver international : official journal of the International Association for the Study of the Liver · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
BACKGROUND AND
aimsThe second Hepatitis E Symposium was held as an integral part of the International DFG/DZIF Joint Meeting on Viral Infections of the Liver and the Heart in Berlin. The symposium aimed to provide a comprehensive exploration of hepatitis E virus (HEV) research and bring together clinicians, basic scientists, public health experts, and bioinformaticians from around the world.
methodsThe program comprised two focused thematic sessions with eight invited speakers presenting recent advances in HEV biology, pathogenesis, and clinical impact. In addition, two interactive round table discussions and two poster sessions facilitated the exchange of recent findings and fostered critical debate.
resultsCore topics included current challenges in HEV epidemiology, emerging therapeutic strategies, and advances in the clinical management of HEV infections. The round table discussions fostered intensive interdisciplinary dialogue, identifying key knowledge gaps as potential avenues for collaborative research.
conclusionThis report summarises the data presented at the symposium and outlines the main themes and outcomes of the round table discussions, highlighting both the progress made and the future directions for HEV research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.